Literature DB >> 25440860

Intracranial bleeds after minor and minimal head injury in patients on warfarin.

Khaled N Alrajhi1, Jeffrey J Perry1, Alan J Forster1.   

Abstract

BACKGROUND: There is little evidence to guide physicians on management of patients who sustain head injuries while on warfarin.
OBJECTIVES: Our objective was to determine the rate of intracranial bleeding in anticoagulated patients with minor and minimal head injuries and the association with clinical features and international normalized ratio (INR).
METHODS: We conducted a historical cohort study of adult patients, taking warfarin, at two tertiary care emergency departments over 2 years with minor (Glasgow Coma Score 13-15, with loss of consciousness, amnesia, or confusion) or minimal (Glasgow Coma Score 15 without loss of consciousness, amnesia, or confusion) head injuries. Patients with penetrating injuries, INR < 1.5, or a new focal neurological deficit were excluded. Our outcome, intracranial bleeding, was determined by the radiologist's final computed tomography (CT) report for imaging performed within 2 weeks.
RESULTS: There were 176 patients enrolled, of which 157 (89.2%) had CT and 28 (15.9%) had intracranial bleeding. Comparing patients with and without intracranial bleeding found no significant differences in INR, and loss of consciousness was associated with higher rate of intracranial bleeding. The rate of intracranial bleeding in the minor and minimal head injury groups was 21.9% and 4.8%, respectively.
CONCLUSIONS: The rate of intracranial bleeding in patients on warfarin is considerable. Loss of consciousness is associated with high rates of intracranial bleeding. This study supports a low threshold for ordering CT scans for anticoagulated patients with head injuries.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  anticoagulants; intracranial hemorrhages; minor head injury

Mesh:

Substances:

Year:  2014        PMID: 25440860     DOI: 10.1016/j.jemermed.2014.08.016

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  5 in total

1.  Predictors of post-traumatic complication of mild brain injury in anticoagulated patients: DOACs are safer than VKAs.

Authors:  Alessandro Cipriano; Naria Park; Alessio Pecori; Alessandra Bionda; Michele Bardini; Francesca Frassi; Valentina Lami; Francesco Leoli; Maria Laura Manca; Stefano Del Prato; Massimo Santini; Lorenzo Ghiadoni
Journal:  Intern Emerg Med       Date:  2021-01-01       Impact factor: 3.397

2.  Intracranial hemorrhage in anticoagulated patients with mild traumatic brain injury: significant differences between direct oral anticoagulants and vitamin K antagonists.

Authors:  Alessandro Cipriano; Alessio Pecori; Alessandra Eugenia Bionda; Michele Bardini; Francesca Frassi; Francesco Leoli; Valentina Lami; Lorenzo Ghiadoni; Massimo Santini
Journal:  Intern Emerg Med       Date:  2018-03-08       Impact factor: 3.397

3.  Head injury in the elderly - an overview for the physician.

Authors:  William Beedham; George Peck; Simon E Richardson; Kevin Tsang; Michael Fertleman; David Jh Shipway
Journal:  Clin Med (Lond)       Date:  2019-03       Impact factor: 2.659

4.  Rates of Intracranial Hemorrhage in Mild Head Trauma Patients Presenting to Emergency Department and Their Management: A Comparison of Direct Oral Anticoagulant Drugs with Vitamin K Antagonists.

Authors:  Gabriele Savioli; Iride Francesca Ceresa; Sabino Luzzi; Cristian Gragnaniello; Alice Giotta Lucifero; Mattia Del Maestro; Stefano Marasco; Federica Manzoni; Luca Ciceri; Elia Gelfi; Giovanni Ricevuti; Maria Antonietta Bressan
Journal:  Medicina (Kaunas)       Date:  2020-06-23       Impact factor: 2.430

5.  Acute and Delayed Intracranial Hemorrhage in Head-Injured Patients on Warfarin versus Direct Oral Anticoagulant Therapy.

Authors:  Patrick G Hughes; Scott M Alter; Spencer W Greaves; Benjamin A Mazer; Joshua J Solano; Richard D Shih; Lisa M Clayton; Nhat Q Trinh; Lawrence Lottenberg; Mary J Hughes
Journal:  J Emerg Trauma Shock       Date:  2021-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.